Crescendo Biologics

Crescendo Biologics

  • Home
  • About Us
    • Overview
    • Investors
    • Strategic Collaborations
  • Our Science
    • Humabody® VH Platform
  • News & Events
    • Press Releases
    • Publications
  • Contact Us
  • LinkedIn
  • Twitter
  • Contact Us
  • Home
  • About Us
    • Overview
    • Investors
    • Strategic Collaborations
  • Our Science
    • Humabody® VH Platform
  • News & Events
    • Press Releases
    • Publications
  • Home
  • About Us
    • Overview
    • Investors
    • Strategic Collaborations
  • Our Science
    • Humabody® VH Platform
  • News & Events
    • Press Releases
    • Publications
  • Contact Us
  • LinkedIn
  • Twitter

BIO 2019

03-06 June 2019
BIO 2019
James Legg and Brian McGuinness to attend
Philadelphia, US

Post navigation

Previous PostPrevious 2019 ASCO Annual Meeting
Next PostNext Champions Oncology 1st Annual Oncology Drug Discovery Symposium

Recent Posts

  • Crescendo Biologics enters pre-clinical collaboration with Orano Med to explore Targeted Alpha Therapy
  • Hello world!
  • Clinical Development
  • Crescendo Biologics and Cancer Research UK sign Clinical Development Partnership to develop CB213, a novel bispecific Humabody® therapeutic
  • Chief Medical Officer

Recent Comments

    Archives

    • July 2020
    • May 2020
    • February 2020
    • January 2020
    • October 2019
    • September 2019
    • July 2019

    Categories

    • Front Page
    • In the News
    • PR & News
    • Uncategorised
    • Videos

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Humabody® and Multibody® are registered trademarks of Crescendo Biologics Limited.
    Privacy and Cookies Notice Cambridge Web Design

    We use cookies to give you a better experience on our website. To find out more, and to manage your preferences, please consult our Privacy and Cookie Notice.